NCT01232283 Study to Evaluate Safety and Effectiveness of Oral Apremilast (CC-10004) in Patients With Moderate to Severe Plaque Psoriasis. Status COMPLETED Phase PHASE3
NCT01230138 Pivotal Efficacy and Safety Registration Trial of FP187 in Moderate to Severe Plaque Psoriasis Status COMPLETED Phase PHASE2
NCT01228656 Effectiveness of Association Mometasone Furoate 0.1% and Salicylic Acid 5% Compared With Mometasone Furoate Status SUSPENDED Phase PHASE2
NCT01194219 Study to Evaluate Safety and Effectiveness of Oral Apremilast (CC-10004) in Patients With Moderate to Severe Plaque Psoriasis Status COMPLETED Phase PHASE3
NCT01166646 Blinded Study of Topical Investigational Lotion Vs. Approved Cream in Treatment of Plaque Psoriasis Status COMPLETED Phase PHASE2
NCT01140061 Safety, Tolerability and Pharmacokinetics of MK-0873 Following Patch Application in Healthy Participants and Psoriasis Participants (MK-0873-020) Status COMPLETED Phase PHASE1
NCT01111123 Ammonium Lactate Lotion 12% (Lac-hydrin®) and Halobetasol Propionate Ointment 0.05% (Ultravate®) in the Treatment and Maintenance of Psoriasis Status COMPLETED Phase PHASE4
NCT01010542 Study Evaluating Single Dose Of ILV-095 In Psoriasis Subjects Status TERMINATED Phase PHASE1
NCT00988637 Evaluate Safety/Efficacy of Two Treatment Regimens for Vectical™ Ointment & Clobex® Spray for Moderate Plaque Psoriasis Status COMPLETED Phase PHASE4
NCT00927069 Safety and Efficacy of Adalimumab in Patients Who Showed an Unsatisfactory Response to Etanercept Status COMPLETED Phase PHASE3
NCT00924950 Taclonex Ointment With Hydrogel Patch Occlusion for the Treatment of Psoriasis Status TERMINATED Phase PHASE4
NCT00884169 Study to Investigate the Efficacy and the Safety of M518101 in Psoriasis Patients Status COMPLETED Phase PHASE2
NCT00833729 The Safety & Efficacy of Etanercept in Psoriasis Patients Who Have Not Responded to Adalimumab Status COMPLETED Phase PHASE4
NCT00832364 Trial of an Injectable Biologic and U0279 as Combination Therapy for Severe Plaque-Type Psoriasis Status WITHDRAWN Phase PHASE4
NCT00796211 A Single-Center Exploratory Study to Assess the Activity of CRx-197-002 in Plaque Psoriasis Status COMPLETED Phase PHASE2
NCT00747032 To Demonstrate the Superior Efficacy of NYC 0462 Ointment Over That of the Placebo in the Treatment of Plaque Psoriasis Status WITHDRAWN Phase PHASE3
NCT00746434 A Proof of Concept Study With 0.5% Roflumilast Cream in Patients With Mild to Moderate Plaque Psoriasis Status WITHDRAWN Phase PHASE2
NCT00733954 Efficacy/Safety/Subject Satisfaction/Duration of Response of Clobetasol Propionate Spray vs Ointment in Plaque Psoriasis Status COMPLETED Phase PHASE4